Brief: Chemours Q2 Adjusted EPS USD 0.38 Vs. IBES Estimate USD 0.57
01/08/2024 21:15
Aug 01 (Reuters) - Chemours Q2 adjusted net income USD 57 million vs. IBES estimate USD 73.9 million. * Q2 adjusted EBITDA USD 206 million vs. IBES estimate USD 219.3 million * Q2 sales USD 1,500 million vs. IBES estimate USD 1,530 million
Recent news on The Chemours
See all newsUS RESEARCH ROUNDUP-Essex Property Trust, Qualys, Vulcan Materials
3M, DuPont must face Connecticut firefighters' lawsuit over 'forever chemicals'
Chemours, DuPont, Corteva settle North Carolina 'forever chemicals' claims for $455 million
U.S. RESEARCH ROUNDUP-Argan, Mastec, Oracle
New Jersey's $2.5 billion 'forever chemicals' settlements with DuPont, 3M, others win court approval